Skip to main content

Woodline Partners LP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,201,110
+$3,444,490 QoQ
Shares Held
846,387
+0.1% QoQ
Ownership
0.760%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#26
of 205 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $232,519,537 across 16 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 AMLX
Amylyx Pharmaceuticals, Inc.
This page
846,387 $15,201,110

All Filings in AMLX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,201,110 846,387
2026-03-31 $11,756,620 845,800
2025-12-31 $10,212,528 845,408
2025-09-30 $11,487,491 845,290
2025-06-30 $7,693,858 1,200,290
2025-03-31 $5,697,442 1,609,447
2024-06-30 $995,166 523,772
2024-03-31 $1,487,512 523,772
2023-12-31 $6,930,190 470,801
2023-09-30 $16,466,183 899,300
2023-06-30 $19,397,901 899,300
2023-03-31 $12,739,428 434,200
2022-12-31 $18,783,643 508,353
2022-09-30 $28,723,809 1,020,384
2022-06-30 $7,515,810 390,229
2022-03-31 $5,014,442 390,229